Evogene
EVGN
35 hedge funds and large institutions have $2.73M invested in Evogene in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
260% more capital invested
Capital invested by funds: $760K → $2.73M (+$1.98M)
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
25% more funds holding
Funds holding: 28 → 35 (+7)
0.76% more ownership
Funds ownership: 0.17% → 0.93% (+0.76%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$2.63M |
| 2 |
Walleye Capital
New York
|
+$453K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$229K |
| 4 |
Morgan Stanley
New York
|
+$42.9K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$34.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$29.4K |
| 2 |
VF
Virtu Financial
New York
|
-$13.8K |
| 3 |
QC
Quent Capital
New York
|
-$12.8K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$1.32K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$438 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SPIA
26
Steward Partners Investment Advisory
New York
| $2.93K | – | – | – |
|
|
CG
27
Cutler Group
San Francisco,
California
| $1K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $956 | -$26 | -3 | -2% |
|
|
29
Group One Trading
Chicago,
Illinois
| $660 | -$1.32K | -151 | -57% |
|
|
AWM
30
Avior Wealth Management
Omaha,
Nebraska
| $58 | – | – | – |
|
|
CAS
31
Coppell Advisory Solutions
Coppell,
Texas
| $42 | +$26 | +3 | +100% |
|
32
Qube Research & Technologies (QRT)
London,
United Kingdom
| $29 | +$44 | +5 | New |
|
33
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $12 | +$18 | +2 | New |
|
|
34
Jane Street
New York
| – | -$29.4K | -2,747 | Closed |
|
|
QC
35
Quent Capital
New York
| – | -$12.8K | -1,200 | Closed |
|
36
Simplex Trading
Chicago,
Illinois
| – | -$70 | -8 | -17% |
|
EVGN Hedge Fund Activity: Q3 2023 in Review
35 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2023, worth a combined $2.73M — up 260% from $760K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new EVGN positions and 2 closed out — a net gain of 7 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Silverarc Capital Management, adding an estimated $2.63M. The largest seller was Jane Street, exiting entirely with an estimated $29.4K sold.
- 35 institutional investors held Evogene (EVGN) as of Q3 2023, up from 28 in Q2 2023.
- Funds reported $2.73M of Evogene stock for Q3 2023, up 260% quarter-over-quarter.
- 9 funds opened new Evogene positions in Q3 2023 and 2 closed out, a net change of +7 holders.
- The largest Evogene buyer in Q3 2023 was Silverarc Capital Management, an estimated $2.63M added.
- The largest Evogene seller in Q3 2023 was Jane Street, an estimated $29.4K sold.
Based on aggregated 13F filings for Q3 2023.